SCHEMBL6605596

SCHEMBL6605596

CSc1ccc(C2CC(O)=CC(=O)O2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 5/20 0.35
ESR2 Q92731 3/20 0.35
CYP3A4 P08684 3/20 0.35
ADORA3 P0DMS8 2/20 0.35
MAPT P10636 2/20 0.35
TUBB4A P04350 1/20 0.35
TUBB P07437 1/20 0.35
YES1 P07947 1/20 0.35
TUBA3C P0DPH7 1/20 0.35
TUBA1B P68363 1/20 0.35
TUBA4A P68366 1/20 0.35
TUBB4B P68371 1/20 0.35
TUBB3 Q13509 1/20 0.35
TUBB2A Q13885 1/20 0.35
TUBB8 Q3ZCM7 1/20 0.35
TUBA3E Q6PEY2 1/20 0.35
TUBA1A Q71U36 1/20 0.35
TUBA1C Q9BQE3 1/20 0.35
TUBB6 Q9BUF5 1/20 0.35
TUBB2B Q9BVA1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9050290 0.84 ESR2 (0.35) CYP19A1ESR2CYP3A4ADORA3MAPT
SCHEMBL6607888 0.83 MAOB (0.48) ESR2ESR1MEN1KMT2APOLB
SCHEMBL31607964 0.82 CYP19A1 (0.50) CYP19A1ESR2CYP3A4ADORA3MAPT
SCHEMBL6602817 0.80 ALOX12 (0.53) CYP19A1ESR2CYP3A4ADORA3MAPT
SCHEMBL4206063 0.79 MAOB (0.49) CYP19A1CYP3A4ADORA3MAPTNPC1
SCHEMBL6602578 0.79 CYP1A1 (0.52) CYP19A1CYP3A4ADORA3MAPTNPC1
SCHEMBL6603263 0.79 SLC6A2 (0.39) CYP19A1ESR2CYP3A4ADORA3MAPT
SCHEMBL6609372 0.77 ADORA3 (0.42) CYP19A1CYP3A4ADORA3MAPTNPC1
SCHEMBL6603604 0.76 CYP19A1 (0.35) CYP19A1ESR2CYP3A4ADORA3MAPT
SCHEMBL6607571 0.76 CYP19A1 (0.45) CYP19A1ESR2CYP3A4ADORA3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1142887-B1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents PARKE DAVIS & CO (US) 2004-04-07 EP disclosed
EP-0729463-B1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2002-05-22 EP disclosed
EP-1142887-A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents PARKE, DAVIS & COMPANY (US) 2001-10-10 EP disclosed
US-5936128-A BENZENETHIOL COMPOUNDS AS INTERMEDIATES; BACTERICIDES, VIRICIDES; HIV WARNER-LAMBERT COMPANY (US) 1999-08-10 US disclosed
US-5840751-A ADMINISTERING IN THE TREATMENT OF INFECTION OR DISEASE CAUSED BY A RETROVIRUS WARNER-LAMBERT COMPANY (US) 1998-11-24 US disclosed
US-5789440-A 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents WARNER-LAMBERT COMPANY (US) 1998-08-04 US disclosed
EP-0729464-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729463-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014012-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014011-A2 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed